Oxford Biomedica PLC - Total Voting Rights

Oxford, UK- 1 February 2023: Oxford Biomedica plc, a leading gene and cell therapy group, today announces that in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6. 1 R, the Company's issued share capital as at the close of business on 31 January 2023 consisted of 96,272,993 ordinary shares of 50 pence each. Oxford Biomedica is based across...